Match!
Kazuyuki Shimada
National Institutes of Health
897Publications
64H-index
19.5kCitations
Publications 905
Newest
#1Seiji Umemoto (Hiroshima University)H-Index: 18
#2Toshio Ogihara (Morinomiya University of Medical Sciences)H-Index: 96
Last.Takao Saruta (Keio: Keio University)H-Index: 64
view all 9 authors...
Source
#1Eri Ishikawa (Nagoya University)H-Index: 3
#2Masanao Nakamura (Nagoya University)H-Index: 22
Last.Mitsuhiro Fujishiro (Nagoya University)H-Index: 1
view all 13 authors...
Background Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease and the most common gastrointestinal lymphoma. The prognostic/predictive indicators among patients with gastric and intestinal DLBCL (giDLBCL) are controversial beyond their anatomical sites. We compared giDLBCL cases and investigated the clinical utility of newly emerging indicators with an emphasis on programmed cell death ligand 1 (PD-L1) expression.
Source
#1Ahmed E. Eladl (Nagoya University)H-Index: 3
#2Kazuyuki Shimada (Nagoya University)H-Index: 64
Last.Akira Satou (Aichi Medical University)H-Index: 7
view all 13 authors...
Source
#1Kazuo KitagawaH-Index: 47
#2Yasumasa YamamotoH-Index: 12
Last.Kazuyuki ShimadaH-Index: 64
view all 24 authors...
Importance The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated that a systolic blood pressure (BP) target less than 120 mm Hg was superior to less than 140 mm Hg for preventing vascular events. This trial excluded patients with prior stroke; therefore, the ideal BP target for secondary stroke prevention remains unknown. Objective To assess whether intensive BP control would achieve fewer recurrent strokes vs standard BP control. Design, Setting, and Participants Randomized clini...
3 CitationsSource
#1Katsuyuki AndoH-Index: 32
#2Kazuyuki ShimadaH-Index: 64
Last.Yasuo IkedaH-Index: 71
view all 12 authors...
Source
#1Masahiro SugawaraH-Index: 22
#2Yoshio GotoH-Index: 22
Last.Yasuo Ikeda (Waseda University)H-Index: 71
view all 13 authors...
Introduction This post hoc subanalysis of the randomized Japanese Primary Prevention Project investigated whether once-daily low-dose aspirin versus no aspirin reduced the risk of cardiovascular events (CVEs) in patients aged ≥ 70 years with atherosclerotic risk factors.
Source
#1Kazuomi Kario (Jichi Medical University)H-Index: 65
#2Eiichiro Yamamoto (Kumamoto University)H-Index: 25
Last.Kazuyuki ShimadaH-Index: 64
view all 8 authors...
1 CitationsSource
#1Kazuo Eguchi (Jichi Medical University)H-Index: 37
#2Hiroshi Miyashita (Jichi Medical University)H-Index: 19
Last.Kazuyuki ShimadaH-Index: 64
view all 20 authors...
It is not established whether central blood pressure (BP) evaluated by a radial pulse wave analysis is useful to predict cardiovascular prognoses. We tested the hypothesis that central BP predicts future cardiovascular events in treated hypertensive subjects. We conducted a multicenter, observational cohort study of 3566 hypertensives being treated with antihypertensive medications at 27 institutions in Japan. We performed the radial pulse wave analyses using applanation tonometry in all subject...
3 CitationsSource
#1Kazuomi Kario (Jichi Medical University)H-Index: 65
#2Mikio Iwashita (Daiichi Sankyo)H-Index: 4
Last.Kazuyuki ShimadaH-Index: 64
view all 8 authors...
SPRINT (Systolic Blood Pressure Intervention Trial) demonstrated the benefit of achieving strict blood pressure control with a lower target blood pressure level in high-risk patients with hypertens...
3 CitationsSource
#1Ikuo Saito (Keio: Keio University)H-Index: 35
#2Kazuomi Kario (Jichi Medical University)H-Index: 65
Last.Kazuyuki ShimadaH-Index: 64
view all 9 authors...
ABSTRACTThe appropriate target blood pressure (BP) in elderly patients with hypertension remains uncertain. We investigated the relationship between morning home systolic blood pressure (MHSBP) during follow-up and cardiovascular (CV) risk in outpatients receiving olmesartan-based treatment aged <75 years (n = 16799) and ≥75 years (n = 4792) in the HONEST study. In the follow-up period (mean 2.02 years), the risk for major CV events was significantly higher in patients with MHSBP ≥155 mmHg compa...
1 CitationsSource
12345678910